BioSpace News Archive

Genetown

T1D Exchange to Present 14 Studies at 79th American Diabetes Association Scientific Sessions

Patient-centered research and clinical studies coupled with device data provide new insights for improving outcomes and quality of life for people living with type 1 diabetes

June 8, 2019
·
3 min read
Biotech Bay

New Recommendations for Time-in-Range Targets During Continuous Glucose Monitoring Presented Today at the ADA’s Scientific Sessions

43 experts from around the globe create the International Consensus on Time-in-Range (TIR) with clinical CGM targets to supplement the currently agreed-upon metrics for CGM-derived times in glucose ranges

June 8, 2019
·
7 min read
Biotech Bay

High Blood Pressure and Elevated Glucose Levels Present Comparable Risk for Young Adults with Type 1 Diabetes to Develop Heart Disease

Study of more than 600 people over 25 years indicates lower blood pressure goals beneficial

June 8, 2019
·
7 min read
Genetown

Fractyl’s Revita DMR Same-Day Therapeutic Procedure Could End Daily Insulin Injections for Type 2 Diabetes Patients

Interim clinical data to be presented at ADA 2019 show that approximately 85 percent of patients are insulin-free at six months after Revita DMR outpatient therapy

June 8, 2019
·
5 min read
Biotech Bay

The iLet Bionic Pancreas Increased Time in Range for Adults with Type 1 Diabetes

Study presented at ADA’s Scientific Sessions compared insulin-only mode of iLet to usual care

June 8, 2019
·
6 min read
Biotech Bay

Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early Type 2 Diabetes

Analysis of data over a two-year period finds losing weight and minimizing weight regain can potentially lead to remission of type 2 diabetes

June 8, 2019
·
10 min read
Pharm Country

One Drop Launches 8-Hour Blood Glucose Forecasts for People with Type 2 Diabetes on Insulin

One Drop launches 8-hour blood glucose forecasts, expanding upon the company’s AI-powered Automated Decision Support and making One Drop the first and only provider of blood glucose forecasts for people with type 2 diabetes

June 8, 2019
·
3 min read
Biotech Bay

Dance Biopharm Presents Encouraging Data from Phase 2 Clinical Trial of Dance 501 Inhaled Insulin Therapy at American Diabetes Association Meeting

Dance Biopharm Holdings, Inc. presented Phase 2 Samba 04 clinical trial results for its inhaled preservative-free human insulin, Dance 501, for the treatment of type 2 diabetes.

June 8, 2019
·
4 min read
Policy

Researchers Find Accelerating Rates of Severe Complications in Young Adults with Youth-Onset Type 2 Diabetes

TODAY2 study data show more intensive management and monitoring required, according to research presented at ADA’s Scientific Sessions

June 8, 2019
·
7 min read
Lilly’s tirzepatide demonstrates benefits in data presented at the American Diabetes Association’s® 79ᵗʰ Scientific Sessions®

Results from several studies of Eli Lilly and Company’s investigational dual GIP and GLP-1 receptor agonist, tirzepatide, reinforce its potential in lowering A1C and body weight in people with type 2 diabetes.

June 8, 2019
·
8 min read